Ronovo Surgical, a minimally invasive surgery device maker based in Shanghai, has reportedly raised “tens of millions” of US dollars in a Pre-Series B financing round led by LongRiver Investments. Other investors included Lilly Asia Ventures, Vivo Capital, Matrix Partners, and GGV Capital. The proceeds will be used for multi-specialty clinical trials for the modular surgical robot, platform product development, and clinical capacity construction and talent recruitment.
Company Background and Focus
Founded in 2019, Ronovo is focused on the digitalization and intelligentization of minimally invasive surgeries. The company, boasting strong global clinical and technology resources, has established long-term and close partnerships with multiple experts and clinical consultants in the surgical robot field. Ronovo is developing a modular and dexterous laparoscopic surgery robot system, positioning itself at the forefront of innovation in surgical technology.
Future Prospects and Strategic Use of Funds
The Pre-Series B financing round positions Ronovo Surgical to further enhance its capabilities in minimally invasive surgery. By investing in multi-specialty clinical trials, platform product development, and clinical capacity construction, Ronovo aims to solidify its position as a leader in the surgical robot field, addressing significant unmet medical needs and improving patient outcomes through advanced surgical solutions.-Fineline Info & Tech
